Progyny (PGNY) shares surged 5.44% in after-hours trading following the release of its impressive third-quarter 2025 financial results. The fertility benefits management company reported revenue of $313.35 million, surpassing analyst expectations of $299.26 million. Adjusted earnings per share came in at $0.45, significantly beating the consensus estimate of $0.29.

The company's strong performance was driven by robust member engagement and the addition of over 80 new clients, bringing approximately 900,000 new covered lives. Progyny also raised its full-year 2025 revenue guidance to $1.263 billion - $1.278 billion, reflecting confidence in its growth trajectory. CEO Pete Anevski noted that new programs like pregnancy-postpartum and menopause care are resonating well in the market.

Adding to investor optimism, Progyny's board authorized a share repurchase program of up to $200 million, signaling confidence in the company's financial position and future prospects. This combination of strong financial results, raised guidance, and the share buyback announcement likely contributed to the significant after-hours stock price increase.